C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939)
12/2006
12/28/2006	WO2006094920A3 Process for the preparation of 1-aminopiperidine derivatives
12/28/2006	WO2006044645A3 Sulfamoyl benzamides and methods of their use
12/28/2006	WO2006009789A3 Aryl-substituted piperazine derivatives
12/28/2006	US20060293525 Optically active alpha-aminooxyketone derivatives and process for production thereof
12/28/2006	US20060293518 Proccess for the preparation of phenylcarbamates
12/28/2006	US20060293515 Imino and amino sugar purification
12/28/2006	US20060293405 Pyridone azo compound, tautomer thereof, and colorant-containing curable composition, color filter and manufacturing method thereof
12/28/2006	US20060293367 Amorphous N-(2-((4-hydroxyphenyl)amino)pyridin-3-yl)-4-methoxybenzenesulfonamide
12/28/2006	US20060293360 4-(2-Phenyloxyphenyl)-piperidine or-1,2,3,6-tetrahydropyridine derivatives as serotonin reuptake inhibitors
12/28/2006	CA2613213A1 Novel compounds of the family of iminosugars, uses thereof for treating lysosomal diseases, and method for preparing same
12/28/2006	CA2611687A1 Benzamide derivatives and uses related thereto
12/28/2006	CA2610326A1 Substituted pyrr0lidin-2-0nes , piperidin-2-0nes and isothiazolidine-1, 1-dioxides, their use as kv1.5 potassium channel blockers and pharmaceutical preparations comprising them
12/27/2006	EP1736469A2 Processes for the preparation of (R)-alpha-(2,3-dimethoxyphenyl)-1-[2-(4-Fluorophenyl)ethyl]-4-piperidinemethanol
12/27/2006	EP1736467A1 Novel sulfonamide derivative
12/27/2006	EP1736465A1 Aniline derivatives
12/27/2006	EP1735298A1 Piperidine derivates for the treatment of chemokines mediared disease
12/27/2006	EP1735282A1 Pyrazole compounds and uses related thereto
12/27/2006	EP1735280A1 Aryl sulfonamide and sulfonyl compounds as modulators of ppar and methods of treating metabolic disorders
12/27/2006	EP1735270A1 Diamino alcohols and their use as renin inhibitors
12/27/2006	EP1734942A1 Substituted urea and carbamate, phenacyl-2-hydroxy-3-diaminoalkane, and benzamide-2-hydroxy-3-diaminoalkane aspartyl-protease inhibitors
12/27/2006	EP1379515B1 Lipid lowering biphenylcarboxamides
12/27/2006	EP1222924B1 Anticancer agents
12/27/2006	CN1886421A Hemiasterlin derivatives and uses thereof
12/27/2006	CN1886375A Piperidine compound and method for producing same
12/27/2006	CN1884263A Pregabalin intermediate and process for preparing same
12/27/2006	CN1884262A 4-amino piperidine compounds and their pharmaceutical use
12/26/2006	US7153970 High purity amlodipine benzenesulfonate and a process for its preparation
12/26/2006	US7153960 Synthesis of 4,5-dihydro-pyrazolo[3,4-c]pyrid-2-ones
12/26/2006	US7153883 Carboxylic acids and carboxylic acid isosteres of N-heterocyclic compounds
12/26/2006	US7153868 N-(3-(4-substituted-1-piperidinyl)-1-phenylpropyl) substituted sulfonamides as NK-3 receptor antagonists
12/26/2006	US7153858 antiserotonine agents; central nervous system disorders; anxiolytic agents; attention deficit disorders; strokes; headaches
12/21/2006	WO2006135860A1 Sulfonamide compounds and uses thereof
12/21/2006	WO2006135828A2 Trisubstituted amines as phosphodiesterase 4 inhibitors
12/21/2006	WO2006134955A1 1, 2-di(cyclic group)substituted benzene derivative
12/21/2006	WO2006134606A1 A novel process for the preparation of lercanidipine
12/21/2006	WO2006134385A2 Anti-inflammatory agents
12/21/2006	WO2006134384A1 Anti-inflammatory agents
12/21/2006	WO2006134341A1 Therapeutic agents
12/21/2006	WO2006133837A2 A process for the preparation of an injectable solution of (2s)-n-(2;6-dimethyl-phenyl)-1-propyl-2-piperidincarboxamide
12/21/2006	WO2006041831A3 Cyclic β-amino acid derivatives as factor xa inhibitors
12/21/2006	WO2005118538A3 Arylsulfonamides and uses as hydroxysteroid dehydrogenase
12/21/2006	US20060287368 Amide derivative of amlodipine
12/21/2006	US20060287363 Substituted 2-carbonylamino-6-piperidinaminopyridines and substituted 1-carbonylamino-3-piperidinaminobenzenes as 5-ht 1f agonists
12/21/2006	US20060287362 Organic compounds
12/21/2006	US20060287361 Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof as opoid receptors ligands
12/21/2006	US20060287298 Pharmaceutical for treatment of neurological and neuropsychiatric disorders
12/21/2006	US20060287293 1-(4-{ethyl-[2-(4-methanesulfonylphenyl)-1-methylethyl]amino}butyl)-4-methanesulfonyl-[1,4]diazepan-2-one; repiratory system disorders: asthma and chronic obstructive pulmonary disease; nervous system, muscular,urogenital, gastrointestinal disorders; antiallergens; side effect reduction
12/21/2006	CA2612298A1 Anti-inflammatory agents
12/21/2006	CA2612217A1 Anti-inflammatory agents
12/21/2006	CA2611562A1 Trisubstituted amines as phosphodiesterase 4 inhibitors
12/21/2006	CA2611493A1 Sulfonamide compounds and uses thereof
12/21/2006	CA2611376A1 Therapeutic agents
12/21/2006	CA2607054A1 1, 2-di(cyclic group)substituted benzene derivative
12/20/2006	EP1734037A2 Processes for the preparation of (R)-alpha-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol"
12/20/2006	EP1733726A1 Pharmaceutically active isoindoline derivatives
12/20/2006	EP1732893A2 Alpha aryl or heteroaryl methyl beta piperidino propanamide compounds as orl1-receptor antagonist
12/20/2006	EP1732610A2 Targeted serotonin reuptake inhibitors
12/20/2006	EP1732552A2 2,6-disubstituted piperidines as modulators of chemokine receptor activity
12/20/2006	EP1651220B1 2-[4- (2-hydroxymethyl-phenylamino)-piperidin-1-yl] - n-(9h-carbazol-3-yl) - acetamide derivatives and related compounds as neuropeptide y5 (npy5) ligands for the treatment of obesity
12/20/2006	EP1648458B1 2-[4(phenylamino)-piperidin-1-yl]-n-phenyl-acetamide derivatives and related compounds as neuropeptide y5 (npy5) ligands for the treatement of obesity
12/20/2006	EP1631557B1 Cyclic hydroxylamine as psychoactive compounds
12/20/2006	EP1456171B1 Substituted cyclohexane derivatives
12/20/2006	EP1305308B1 Aminopiperidine quinolines and their azaisosteric analogues with antibacterial activity
12/20/2006	EP1288198B1 Process for the production of sulfonic esters
12/20/2006	EP1263729B1 Azacyclic compounds for use in the treatment of serotonin related diseases
12/20/2006	EP1202967B1 Sulfuric acid mono-[3-({1-[2-(4-fluoro-phenyl)-ethyl]-piperidin-4-yl}-hydroxy-methyl)-2-methoxy-phenyl]ester
12/20/2006	CN1882577A 喹唑啉衍生物 Quinazoline derivatives
12/20/2006	CN1882543A Process for preparation of chiral amlodipine salts
12/20/2006	CN1882542A 2-pyridone derivatives as neutrophil elastase inhibitors and their use
12/20/2006	CN1882541A derivatives of n-[phenyl(alkylpiperidine-2-yl)methyl]benzamide, preparation method thereof and application of same in therapeutics
12/20/2006	CN1882540A Derivatives of n-phenyl(piperidine-2-yl)methyl benzamide, preparation method thereof and applications of same in therapeutics
12/20/2006	CN1882536A 3-aminopyrrolidone derivatives
12/20/2006	CN1882530A Amidines and derivatives thereof and pharmaceutical compositions containing them
12/20/2006	CN1880306A Substituted indeno[1,2-c]isoquinoline derivatives and methods of use thereof
12/20/2006	CN1290843C Polymorph of acid 4-[2-[4-[1-2-ethoxyethyl]-1h-benzimidazole-2-il]-1-piper idinyl]ethyl]-alpha, alpha-dimethyl-benzeneacetic acid
12/19/2006	US7151181 Process for the preparation of 3,5-diethyl-1,2-dihydro-1-phenyl-2-propylpyridine
12/19/2006	US7151118 N-(6-Methyl-4'-{[3-(4-methylpiperazin-1-yl)propylamino]carbonyl}-1,1'-biphenyl-3-yl)-2-pyrrolidin-1-ylisonicotinamide; enzyme inhibitors for the treatment of certain diseases and conditions; chemical synthesis
12/19/2006	US7151107 A quaternary ammonium salts of 1-{2-(3'-chlorobiphenyl-4-yl)-2-oxoethyl}-4-(3-trifluoromethyl-phenyl)-1,2,3,6-tetrahydropyridine; used as neuroprotectants, for prophylaxis of brain and nervous system disorders, Alzheimer's disease, senile dementia
12/19/2006	CA2362836C Process for the preparation of 1,5-dideoxy-1,5-imino hexitols from oximes or imines
12/19/2006	CA2264979C Dicyclic-aromatic compounds and their application in human and veterinary medicine, as well as in cosmetics
12/19/2006	CA2155200C Use of topical anesthetics for the treatment of eosinophil-associated diseases
12/14/2006	WO2006133326A1 Inhibitors of hcv replication
12/14/2006	WO2006131773A1 Process for the preparation of s-(-)-amlodipine
12/14/2006	WO2006131711A1 Cyclohexanesulfonyl derivatives as glyt1 inhibitors to treat schizophrenia
12/14/2006	WO2006131524A1 Novel n-phenyl-piperidine derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
12/14/2006	WO2006073589A3 Cycloalkyl keto piperidine tachykinin receptor antagonists
12/14/2006	US20060281920 such as 6-(4-ethoxy-phenyl)-2S-hydroxy-3R-[4-(3-methoxy-phenyl)-piperazine-1-carbonyl]-hexanoic acid hydroxyamide, used for the treatment or prophylaxis of arthritis in mammals
12/14/2006	US20060281746 neurokinin receptor 3 (NK3) antagonists; psychological disorders, inflammatory bowel disease, asthma, ischemia, Parkinson's disease; e.g. (1S,2R)-2-(4-Acetylamino-4-phenyl-piperidin-1-ylmethyl)-1-(3,4-dichlorophenyl)-cyclopropanecarboxylic acid, benzyl-methyl-amide
12/14/2006	US20060281742 Amines that inhibit a mammalian anandamide transporter, and methods of use thereof
12/14/2006	US20060281731 3,4,5-trihydroxy-2-methoxy-8,8-dimethyl-non-enoic acid ((3S,6S)-6-azido-2-oxo-azepan-3-yl)-amide; less toxicity, better selectivity in killing cancer cells, minimal effect on normal healthy cells
12/14/2006	US20060281725 Agents and crystals for improving excretory potency of urinary bladder
12/14/2006	US20060281713 4-{2-[(R)-2-((E)-3-Hydroxy-4-phenyl-but-1-enyl)-6-oxo-piperidin-1-yl]-ethylsulfanyl}-butyric acid or the alkyl ester; glaucoma, intraocular hypotensive agents
12/14/2006	CA2609969A1 Cyclohexanesulfonyl derivatives as glyt1 inhibitors to treat schizophrenia
12/14/2006	CA2600954A1 Compounds and compositions for use in the prevention and treatment of obesity and related syndromes
12/13/2006	EP1731508A1 Weakly basic hindered amines having carbonate skeletons, synthetic resin compositions, and coating compositions
12/13/2006	EP1731507A1 New heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-alzheimer agents
12/13/2006	EP1731505A1 Alkoxyphenylpropanoic acid derivatives
12/13/2006	EP1730141A1 Compounds for the treatment of diseases
12/13/2006	EP1730130A1 Beta-ketoamide compounds having an mch-antagonistic effect and medicaments containing said compounds
12/13/2006	EP1730103A1 Formamide derivatives useful as adrenoceptor

1 ... 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 ... 380